RxDoctor Payments Data

Ryan Hunley, DO

Family Medicine · Sparta, TNNPI 1992233704

Payments from drug & device makers

$1,712in general payments, 2019–2025

Across 82 payments — averaging $20.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$329
  • Amgen$296
  • Lilly USA, LLC$257
  • AbbVie$247
  • Novo Nordisk$177
  • GSK$92
  • plus $316 from 10 others

What the payments were for

  • Food & beverage$1,69999%
  • Education$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,712 in reported general payments places this provider in the 65th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$69,696
Medicare patients
112
Services billed
2,097

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide88$120,730
EliquisApixaban141$114,438
JardianceEmpagliflozin49$42,822
XareltoRivaroxaban31$27,076
TrulicityDulaglutide23$23,580
MounjaroTirzepatide17$18,454
JanuviaSitagliptin Phosphate14$17,751
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$15,483
MyrbetriqMirabegron15$9,947
Lantus SolostarInsulin Glargine,hum.Rec.Anlog58$7,340
Humalog Kwikpen U-100Insulin Lispro19$6,379
Atorvastatin Calcium402$4,662
SymbicortBudesonide/Formoterol Fumarate12$4,279
Omeprazole235$3,628
Dexlansoprazole DrDexlansoprazole15$3,385

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$177$120,73088 claims
Lilly USA, LLCTrulicity, Mounjaro$257$42,03440 claims
GSKTrelegy Ellipta$92$15,48317 claims
Astellas Pharma US IncMyrbetriq$18$9,94715 claims
AstraZenecaSymbicort$45$4,27912 claims
Sanofi-aventis U.S. LLCLantus$47$90611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Sparta

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →